BSE · SHUKRAPHAR.BO
Shukra Pharmaceuticals Limited
₹76.78+₹1.79 (+2.39%)
Shukra Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
Loading market information…
BSE · JENBURPH.BO · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:39 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Jenburkt Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 35.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jenburkt Pharmaceuticals Limited’s forward annual dividend is ₹20.70 per share, paid annual. The forward yield is 2.44% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jenburkt Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jenburkt Pharmaceuticals Ltd. specializes in the creation and commercialization of a wide array of medicinal formulations and healthcare products. Its extensive product range includes treatments for parasitic infestations (anthelmintic), bone density disorders (anti-osteoporotic), joint inflammation (anti-arthritic), stomach ulcers (anti-ulcerants), and bacterial infections (antibiotics). The company also provides aphrodisiacs, remedies for coughs and colds, and dermatological solutions for allergies. Operations are structured into two main divisions: domestic sales and international exports. Jenburkt Pharmaceuticals was founded on June 10, 1985, by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta, and Harshad N. Bhuta, and its corporate headquarters are located in Mumbai, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹76.78+₹1.79 (+2.39%)
Shukra Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
₹1,390.00-₹60.60 (-4.18%)
Fredun Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.58% below the high.
₹448.50-₹8.50 (-1.86%)
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 6.55% below the high.
₹34.80-₹0.20 (-0.57%)
Ambalal Sarabhai Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 30.37% below the high.
₹414.30+₹14.00 (+3.5%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 32.08% below the high.
₹173.55+₹5.15 (+3.06%)
Sanjivani Paranteral Limited.’s quoted price sits in the lower half of its reported 52-week range, 28.87% below the high.
₹125.90+₹2.70 (+2.19%)
Godavari Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 12.78% below the high.
₹100.05-₹1.10 (-1.09%)
Panchsheel Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 35.2% below the high.
